Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.73 - $1.34 $5,564 - $10,213
-7,622 Reduced 4.53%
160,603 $129,000
Q4 2021

Feb 08, 2022

SELL
$0.99 - $1.2 $342 - $415
-346 Reduced 0.21%
168,225 $167,000
Q3 2021

Nov 15, 2021

SELL
$1.08 - $1.49 $4,909 - $6,773
-4,546 Reduced 2.63%
168,571 $184,000
Q2 2021

Aug 13, 2021

BUY
$1.17 - $1.59 $29,127 - $39,583
24,895 Added 16.8%
173,117 $242,000
Q1 2021

May 12, 2021

BUY
$1.38 - $2.28 $33,136 - $54,747
24,012 Added 19.33%
148,222 $224,000
Q4 2020

Feb 11, 2021

BUY
$1.2 - $1.69 $42,876 - $60,383
35,730 Added 40.38%
124,210 $169,000
Q3 2020

Nov 16, 2020

BUY
$1.21 - $2.23 $37,789 - $69,645
31,231 Added 54.55%
88,480 $125,000
Q2 2020

Aug 14, 2020

BUY
$0.42 - $1.26 $3,163 - $9,490
7,532 Added 15.15%
57,249 $72,000
Q4 2019

Feb 14, 2020

SELL
$0.32 - $3.15 $96 - $945
-300 Reduced 0.6%
49,717 $19,000
Q3 2019

Nov 13, 2019

SELL
$1.79 - $3.33 $1,432 - $2,664
-800 Reduced 1.57%
50,017 $141,000
Q4 2018

Feb 12, 2019

SELL
$1.07 - $1.63 $214 - $326
-200 Reduced 0.39%
50,817 $66,000
Q2 2018

Aug 14, 2018

BUY
$1.06 - $1.78 $8,057 - $13,529
7,601 Added 17.51%
51,017 $66,000
Q4 2017

Feb 14, 2018

BUY
$3.36 - $4.35 $3,951 - $5,115
1,176 Added 2.78%
43,416 $149,000
Q3 2017

Nov 13, 2017

BUY
$3.67 - $4.19 $155,020 - $176,985
42,240
42,240 $167,000

About Lipocine Inc.


  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $434M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.